Avo vs KATE
Triage acuity and sepsis flags are an emergency department nursing director's concern, and no-code pathway building is a chief medical information officer's, which keeps the two off one shortlist. KATE, from Mednition in Burlingame, recommends a triage acuity level and flags sepsis risk from EHR data at triage. The vendor says it needs no workflow change, and the homepage names no EHR. A 2019 vendor release claimed triage accuracy up 26.9% at Adventist Health White Memorial. Three PubMed papers under Mednition's affiliation have Mednition employees as authors, and none of the three titles names KATE. KATE Sepsis holds a Breakthrough Device Designation from November 2023, which is a designation and not a clearance, and an openFDA search by applicant and device name returned no K or DEN number.
Avo's pages describe no-code guideline pathways that a health system builds, an AI Consult chatbot in the EHR, and Chart Assist copilots for admission, rounding and discharge. The vendor claims implementation runs 94% shorter.
Decision support · Reviewed November 2, 2026
When to pick each one
Avo
- No-code guideline pathways built by the health system
- Vendor claims 94% shorter implementation
KATE
- Triage acuity recommendation and sepsis risk flag
- Breakthrough designation for KATE Sepsis, not a clearance
- Adventist Health White Memorial named as customer
Score
Each row shows points earned of points available under the published rubric.
Avo
18of 100
KATE
12of 100
| Dimension | Avo | KATE | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 6 / 10 | 0 / 10 | +6 |
| EHR integrations (count) | 1.7 / 5.6 | 0 / 5.6 | +1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 3.4 / 4.8 | 0 / 4.8 | +3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 0 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Avo
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo booking only. |
KATE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Avo
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
KATE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Avo | KATE |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, athenahealth, MEDITECH | Not specified |
| Founded | n/a | 2014 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


